Related references
Note: Only part of the references are listed.RLC score (R status, lymphovascular invasion, C-reactive protein) predicts survival following radical cystectomy for muscle-invasive bladder cancer
Julian Peter Struck et al.
AKTUELLE UROLOGIE (2022)
Development of novel ACN (albumin, C-reactive protein and neutrophil-to-lymphocyte ratio) prognostication model for patients with metastatic renal cell carcinoma receiving first-line molecular-targeted therapy
Keita Tamura et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2021)
Prognostic value of pretreatment inflammatory markers in variant histologies of the bladder: is inflammation linked to survival after radical cystectomy?
Severin Rodler et al.
WORLD JOURNAL OF UROLOGY (2021)
Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab
Shohei Fukuda et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Feasibility of the ACL (albumin, C-reactive protein and lactate dehydrogenase) model as a novel prognostic tool in patients with metastatic renal cell carcinoma previously receiving first-line targeted therapy
Keita Tamura et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2020)
Impact of Routine Laboratory Parameters in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: A Long-Term Follow-Up
Alexander Tamalunas et al.
UROLOGIA INTERNATIONALIS (2020)
Gender Disparities in Bladder Cancer Specific Survival in High Poverty Areas Utilizing Ohio Cancer Incidence Surveillance System (OCISS)
Laura Bukavina et al.
UROLOGY (2020)
Preoperative C-reactive protein/albumin ratio predicts outcome of surgical papillary renal cell carcinoma
Jie Gao et al.
FUTURE ONCOLOGY (2019)
Neutrophil-to-lymphocyte Ratio, Platelet-to-lymphocyte Ratio, and C-reactive Protein as New and Simple Prognostic Factors in Patients With Metastatic Renal Cell Cancer Treated With Tyrosine Kinase Inhibitors: A Systemic Review and Meta-analysis
Aleksandra Semeniuk-Wojtas et al.
CLINICAL GENITOURINARY CANCER (2018)
Higher Serum C-reactive Protein Level Represents the Immunosuppressive Tumor Microenvironment in Patients With Clear Cell Renal Cell Carcinoma
Takayuki Nakayama et al.
CLINICAL GENITOURINARY CANCER (2018)
Preoperative C-reactive protein/albumin ratio is a significant predictor of survival in bladder cancer patients after radical cystectomy: a retrospective study
Yadong Guo et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma
Orietta Dalpiaz et al.
BRITISH JOURNAL OF CANCER (2017)
The effect of kinetics of C-reactive protein in the prediction of overall survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor
Jun Teishima et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2017)
C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis
Zhun Wang et al.
CLINICA CHIMICA ACTA (2017)
A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma
Rishi R. Sekar et al.
ASIAN JOURNAL OF UROLOGY (2017)
Impact of preoperative hemoglobin and CRP levels on cancer-specific survival in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: results of a single-center study
T. Grimm et al.
WORLD JOURNAL OF UROLOGY (2016)
Prognostic value of inflammation in prostate cancer progression and response to therapeutic: a critical review
Alessandro Sciarra et al.
JOURNAL OF INFLAMMATION-LONDON (2016)
The prognostic role of preoperative serum C-reactive protein in predicting the biochemical recurrence in patients treated with radical prostatectomy
S. Sevcenco et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2016)
Prognostic significance of markers of systemic inflammatory response in patients with non muscle-invasive bladder cancer
Aurelie Mbeutcha et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2016)
Prognostic factors and risk stratification in patients with castration-resistant prostate cancer receiving docetaxel-based chemotherapy
Shimpei Yamashita et al.
BMC UROLOGY (2016)
C-Reactive Protein is a Prognostic Marker for Patients with Castration-Resistant Prostate Cancer
Shao-Guang Liao et al.
ONCOLOGY RESEARCH AND TREATMENT (2016)
The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy
Eva-Maria Thurner et al.
EUROPEAN JOURNAL OF CANCER (2015)
Do preoperative serum C-reactive protein levels predict the definitive pathological stage in patients with clinically localized prostate cancer?
Thomas J. Schnoeller et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2015)
C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review
Shiva Shrotriya et al.
PLOS ONE (2015)
Prognostic Role of C-Reactive Protein In Urological Cancers: A Meta-Analysis
Liang Zhou et al.
SCIENTIFIC REPORTS (2015)
Prognostic role of C-reactive protein in prostate cancer: a systematic review and meta-analysis
Zhu-Qing Liu et al.
ASIAN JOURNAL OF ANDROLOGY (2014)
Interferon-γ-Induced Inflammatory Markers and the Risk of Cancer: The Hordaland Health Study
Hui Zuo et al.
CANCER (2014)
Combination of hemoglobin, alkaline phosphatase, and age predicts optimal docetaxel regimen for patients with castration-resistant prostate cancer
Hideyasu Matsuyama et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2014)
Prognostic Impact of Intratumoral C-Reactive Protein Expression in Patients with Clear Cell Renal Cell Carcinoma
Cavit Can et al.
UROLOGIA INTERNATIONALIS (2014)
The prognostic value of C-reactive protein in renal cell carcinoma: A systematic review and meta-analysis
Qingfeng Hu et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Organ-specific and tumor-size-dependent responses to sunitinib in clear cell renal cell carcinoma
Norihiko Tsuchiya et al.
BMC UROLOGY (2014)
The modified Glasgow prognostic score in prostate cancer: results from a retrospective clinical series of 744 patients
Kashif Shafique et al.
BMC CANCER (2013)
The association between C-reactive protein (CRP) level and biochemical failure-free survival in patients after radiation therapy for nonmetastatic adenocarcinoma of the prostate
William A. Hall et al.
CANCER (2013)
Glasgow Prognostic Score As a Prognostic Factor in Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel-Based Chemotherapy
Anthony Linton et al.
CLINICAL GENITOURINARY CANCER (2013)
The Prostate Cancer Patient Had Higher C-Reactive Protein Than BPH Patient
Youngjun Kim et al.
KOREAN JOURNAL OF UROLOGY (2013)
Impact of C-reactive protein kinetics on survival of patients with advanced urothelial carcinoma treated by second-line chemotherapy with gemcitabine, etoposide and cisplatin
Kazutaka Saito et al.
BJU INTERNATIONAL (2012)
Late recurrence of renal cell carcinoma >5 years after surgery: clinicopathological characteristics and prognosis
Yong Hyun Park et al.
BJU INTERNATIONAL (2012)
Development of a nomogram incorporating serum C-reactive protein level to predict overall survival of patients with advanced urothelial carcinoma and its evaluation by decision curve analysis
J. Ishioka et al.
BRITISH JOURNAL OF CANCER (2012)
Serum Levels of Secreted Group IIA Phospholipase A2 in Benign Prostatic Hyperplasia and Prostate Cancer: A Biomarker for Inflammation or Neoplasia?
Mario Menschikowski et al.
INFLAMMATION (2012)
Utility of Inflammation-based Prognostic Scoring in Patients Given Systemic Chemotherapy First-line for Advanced Inoperable Bladder Cancer
Eu Chang Hwang et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2012)
Prognostic Value of Neutrophil-to-lymphocyte Ratio and Establishment of Novel Preoperative Risk Stratification Model in Bladder Cancer Patients Treated With Radical Cystectomy
Tatsuo Gondo et al.
UROLOGY (2012)
C-reactive protein is a strong predictor for anaemia in renal cell carcinoma: role of IL-6 in overall survival
Claudia E. Falkensammer et al.
BJU INTERNATIONAL (2011)
Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score
Georgios Gakis et al.
BJU INTERNATIONAL (2011)
The Controversial Relationship Between Benign Prostatic Hyperplasia and Prostate Cancer: The Role of Inflammation
Cosimo De Nunzio et al.
EUROPEAN UROLOGY (2011)
Risk of prostate cancer is not associated with levels of C-reactive protein and other commonly used markers of inflammation
Mieke Van Hemelrijck et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Prognostic Impact of C-reactive Protein for Determining Overall Survival of Patients With Castration-resistant Prostate Cancer Treated With Docetaxel
Masaya Ito et al.
UROLOGY (2011)
Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model
Jesus Fernandez-Gomez et al.
JOURNAL OF UROLOGY (2009)
C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy
Soichiro Yoshida et al.
BJU INTERNATIONAL (2008)
C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer
Tomasz M. Beer et al.
CANCER (2008)
C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality - A European study of 313 patients
Pierre I. Karakiewicz et al.
CANCER (2007)
Impact of thrombocytosis and C-reactive protein elevation on the prognosis for patients with renal cell carcinoma
Keiichi Ito et al.
INTERNATIONAL JOURNAL OF UROLOGY (2006)
Clinical significance of urinary white blood cell count and serum C-reactive protein level for detection of non-palpable prostate cancer
Tomonori Kato et al.
INTERNATIONAL JOURNAL OF UROLOGY (2006)
Systemic inflammatory response, prostate-specific antigen and survival in patients with metastatic prostate cancer
Peter A. McArdle et al.
UROLOGIA INTERNATIONALIS (2006)
C-reactive protein is significantly associated with prostate-specific antigen and metastatic disease in prostate cancer
S Lehrer et al.
BJU INTERNATIONAL (2005)
Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer
LM Forrest et al.
BRITISH JOURNAL OF CANCER (2003)
Interleukin-6, tumour necrosis factor α and interleukin-1β in patients with renal cell carcinoma
N Yoshida et al.
BRITISH JOURNAL OF CANCER (2002)
Share Paper
